Leader At-Home 5-Panel Drug Test Kit delivers simultaneous detection of five major drug classes—marijuana, cocaine, opiates, amphetamines, and methamphetamine—through a single immunoassay procedure with >99% analytical accuracy for preliminary screening applications. The urine-based methodology requires minimal specimen handling and no laboratory infrastructure, producing interpretable results within 5 minutes via visual line development. The multiplex design enables comprehensive substance surveillance across diverse monitoring contexts including parental oversight, workplace compliance verification, and personal health assessment. The straightforward single-step protocol eliminates procedural complexity while maintaining sensitivity and specificity standards equivalent to institutional laboratory testing. Results interpretation relies on simple visual assessment without requiring specialized training or equipment calibration. This cost-effective screening solution provides rapid, confidential substance detection suitable for individuals requiring efficient multi-drug surveillance without external laboratory submission or extended result turnaround periods.